WHY PUBLISH WITH KIDNEY CANCER
Submit your manuscript online via Sage Track
PubMed Central submission
Authors can self-submit or get their institution to submit their article to PubMed Central if they are at an NCI-Designated Cancer Center, or have NIH or other relevant funding (see PMC and Research Funder Policies).
Call for Papers
Kidney Cancer is published online only and offers a rigorous review process. The journal also operates with rapid manuscript processing times.
The current APC for the journal is US$1400, discounted from the full rate of US$2800.
Authors may be eligible for discounts to their APC via open access agreements that Sage has with participating institutions. Discounts depend on the terms of the agreement, find out if your institution is participating by visiting the institutional agreements page at IOS Press. Eligibility is determined by the corresponding author’s affiliation at acceptance matching an agreement.
Your article may be eligible for a full or partial waiver due to our participation in initiatives to increase accessibility to publication across the international academic community. More information about discounts and eligibility.
Before you get ready to submit your manuscript, please see the:
